{{Rsnum
|rsid=4319896
|Gene=ALK
|Chromosome=2
|position=29916983
|Orientation=plus
|GMAF=0.4357
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=ALK
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 18.6 | 57.5 | 23.9
| HCB | 21.3 | 43.4 | 35.3
| JPT | 13.3 | 43.4 | 43.4
| YRI | 14.3 | 41.3 | 44.4
| ASW | 21.1 | 49.1 | 29.8
| CHB | 21.3 | 43.4 | 35.3
| CHD | 13.8 | 53.2 | 33.0
| GIH | 17.8 | 42.6 | 39.6
| LWK | 15.5 | 53.6 | 30.9
| MEX | 13.8 | 48.3 | 37.9
| MKK | 23.4 | 50.0 | 26.6
| TSI | 22.5 | 47.1 | 30.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=19346957
|Title=Gene prioritization based on biological plausibility over genome wide association studies renders new loci associated with type 2 diabetes.
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}